Markets:

Overview

News

Currencies

International

Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.660 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CureVac N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Why CureVac (CVAC) Stock Is Moving ↗

January 08, 2025

Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains driven by rising concerns over U.S. respiratory illnesses.

Via Benzinga

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies ↗

January 08, 2025

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Via Benzinga

Topics ETFs

US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally ↗

January 07, 2025

The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses...

Via Benzinga

Why CureVac (CVAC) Stock Is Rising ↗

January 06, 2025

Shares of CureVac are trading higher by 15% during Monday's session. The stock is gaining following a CDC report highlighting a significant increase in acute respiratory illnesses nationwide.

Via Benzinga

2 Small-Cap Stocks Set to Shine in a Bull Market

December 16, 2024

Small-cap growth-orientated stocks like HTCR and CVAC often outperform during bullish markets due to their sensitivity to improving economic conditions.

Via MarketBeat

Topics ETFs

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Insights into CureVac's Upcoming Earnings ↗

November 11, 2024

Via Benzinga

GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine ↗

September 12, 2024

GSK announced positive phase 2 trial results for its mRNA seasonal flu vaccine, showing strong immune.

Via Benzinga

CVAC Stock Earnings: CureVac Misses EPS, Beats Revenue for Q2 2024 ↗

August 20, 2024

CVAC stock results show that CureVac missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q1 2024 ↗

July 12, 2024

CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know ↗

July 03, 2024

Southwest Airlines is in the news Wednesday after the airline company adopted a poison pill to battle activist investor Elliott Management.

Via InvestorPlace

Why Is DouYu (DOYU) Stock Up 44% Today? ↗

July 03, 2024

DouYu stock is up on Wednesday after the company announced a special cash dividend for DOYU investors payable in August.

Via InvestorPlace

CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts ↗

July 03, 2024

CureVac layoffs are coming for 30% of the vaccine company's employees as it prepares for a restructuring that will save it over 30% in costs.

Via InvestorPlace

Topics Workforce

GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery ↗

July 03, 2024

Canoo stock is down on Wednesday as GOEV investors appear unimpressed by the company's new delivery van fleet deal with Go2 Delivery.

Via InvestorPlace

DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million ↗

July 03, 2024

Desktop Metal stock is up on Wednesday as DM investors learn of an acquisition deal with Nano Dimension for the company's shares.

Via InvestorPlace

CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK ↗

July 03, 2024

CureVac stock is up on Wednesday as CVAC investors react to the company signing a new 1.4 billion euro licensing agreement with GSK.

Via InvestorPlace

GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B ↗

July 03, 2024

GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 03, 2024

Pre-market stock movers are worth checking out on Wednesday with our breakdown of all the biggest news affecting shares this morning.

Via InvestorPlace

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 18, 2024

Via Benzinga

First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map ↗

June 06, 2024

Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.

Via Benzinga

Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday ↗

June 05, 2024

Via Benzinga

Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 05, 2024

Via Benzinga

Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday ↗

May 22, 2024

Via Benzinga

Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 22, 2024

Via Benzinga

Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday ↗

May 17, 2024

Via Benzinga

CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023 ↗

May 15, 2024

CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

3 Stocks to Purge ASAP Before They’re Pulled off Life Support ↗

May 10, 2024

Here are three stocks to sell now from your portfolio before they run out of cash and collapse. Avoid throwing good money after bad.

Via InvestorPlace

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗

May 09, 2024

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

Via Benzinga

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday ↗

May 06, 2024

Via Benzinga

COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle ↗

April 26, 2024

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent...

Via Benzinga

Topics Intellectual Property Lawsuit

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CureVac N.V. - Ordinary Shares (NQ:CVAC)

Headline News about CureVac N.V. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today